226 related articles for article (PubMed ID: 23905818)
1. Hepatitis B in HIV-infected patients.
Soriano V; Poveda E; Vispo E; Barreiro P
Clin Liver Dis; 2013 Aug; 17(3):489-501. PubMed ID: 23905818
[TBL] [Abstract][Full Text] [Related]
2. Management and treatment of chronic hepatitis B in HIV-positive patients.
Soriano V; de Mendoza C; Fernández-Montero JV; Labarga P; Barreiro P
Ann Med; 2014 Aug; 46(5):290-6. PubMed ID: 24716736
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy.
Gaglio PJ; Sterling R; Daniels E; Tedaldi E;
Clin Infect Dis; 2007 Sep; 45(5):618-23. PubMed ID: 17682998
[TBL] [Abstract][Full Text] [Related]
4. Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B.
Plaza Z; Aguilera A; Mena A; Vispo E; Sierra-Enguita R; Tomé S; Pedreira J; Rodriguez C; Barreiro P; del Romero J; Soriano V; Poveda E
AIDS; 2013 Sep; 27(14):2219-24. PubMed ID: 23669158
[TBL] [Abstract][Full Text] [Related]
5. HIV and hepatitis B virus: options for managing coinfection.
Dieterich DT
Top HIV Med; 2003; 11(1):16-9. PubMed ID: 12717046
[TBL] [Abstract][Full Text] [Related]
6. Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir.
Mikulska M; Taramasso L; Giacobbe DR; Caligiuri P; Bruzzone B; Di Biagio A; Viscoli C
J Med Virol; 2012 Sep; 84(9):1340-3. PubMed ID: 22825811
[TBL] [Abstract][Full Text] [Related]
7. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
Schmutz G; Nelson M; Lutz T; Sheldon J; Bruno R; von Boemmel F; Hoffmann C; Rockstroh J; Stoehr A; Wolf E; Soriano V; Berger F; Berg T; Carlebach A; Schwarze-Zander C; Schürmann D; Jaeger H; Mauss S
AIDS; 2006 Oct; 20(15):1951-4. PubMed ID: 16988516
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B in HIV patients: what is the current treatment and what are the challenges?
Soriano V; Tuma P; Vispo E; Labarga P; Fernández JV; Medrano J; Barreiro P
J HIV Ther; 2009 Mar; 14(1):13-8. PubMed ID: 19731560
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future.
Núñez M; Puoti M; Camino N; Soriano V
Clin Infect Dis; 2003 Dec; 37(12):1678-85. PubMed ID: 14689351
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus and HIV infection.
Martín-Carbonero L; Poveda E
Semin Liver Dis; 2012 May; 32(2):114-9. PubMed ID: 22760650
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and human immunodeficiency virus co-infection.
Phung BC; Sogni P; Launay O
World J Gastroenterol; 2014 Dec; 20(46):17360-7. PubMed ID: 25516647
[TBL] [Abstract][Full Text] [Related]
12. Quasispecies analysis and in vitro susceptibility of HBV strains isolated from HIV-HBV-coinfected patients with delayed response to tenofovir.
Lada O; Gervais A; Branger M; Peytavin G; Roquebert B; Collin G; Fraqueiro G; Moucari R; Leclerc L; Martinot-Peignoux M; Matheron S; Marcellin P
Antivir Ther; 2012; 17(1):61-70. PubMed ID: 22267470
[TBL] [Abstract][Full Text] [Related]
13. New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients.
Martin-Carbonero L; Soriano V
J Antimicrob Chemother; 2010 Mar; 65(3):379-82. PubMed ID: 20085999
[TBL] [Abstract][Full Text] [Related]
14. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.
Matthews GV; Avihingsanon A; Lewin SR; Amin J; Rerknimitr R; Petcharapirat P; Marks P; Sasadeusz J; Cooper DA; Bowden S; Locarnini S; Ruxrungtham K; Dore GJ
Hepatology; 2008 Oct; 48(4):1062-9. PubMed ID: 18697216
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral therapy and HIV/hepatitis B virus coinfection.
Benhamou Y
Clin Infect Dis; 2004 Mar; 38 Suppl 2():S98-103. PubMed ID: 14986281
[TBL] [Abstract][Full Text] [Related]
17. Tenofovir-based combination therapy for HIV/HBV co-infection: factors associated with a partial HBV virological response in patients with undetectable HIV viraemia.
Childs K; Joshi D; Byrne R; Bruce M; Carey I; Agarwal K; Taylor C
AIDS; 2013 Jun; 27(9):1443-8. PubMed ID: 23435302
[TBL] [Abstract][Full Text] [Related]
18. Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.
Pellicelli AM; Barbaro G; Francavilla R; Romano M; Barbarini G; Mazzoni E; Mecenate F; Paffetti A; Barlattani A; Struglia C; Villani R; Nauri L; Nosotti L; Armignacco O; Ferri F; Camporiondo MP; Soccorsi F;
Clin Ther; 2008 Feb; 30(2):317-23. PubMed ID: 18343270
[TBL] [Abstract][Full Text] [Related]
19. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G.
Lada O; Gervais A; Branger M; Peytavin G; Roquebert B; Collin G; Fraqueiro G; Moucari R; Hamet G; Martinot-Peignoux M; Matheron S; Marcellin P
Liver Int; 2012 Jan; 32(1):93-101. PubMed ID: 22097898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]